Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Michèle CavoEvangelos TerposDepartment of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, GreeceCristina NanniNuclear Medicine, Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalyPhilippe MoreauSuzanne LentzschColumbia University Medical Center, New York, NY, USASonja ZweegmanDepartment of Hematology, VU University Medical Center, Amsterdam, NetherlandsJens HillengaßDepartment of Internal Medicine V, University Hospital Heidelberg, Heidelberg, GermanyMonika EngelhardtDepartment of Medicine, Hematology, Oncology & Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanySaad Z. UsmaniLevine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USADavid H. VesoleJohn Theurer Cancer Center at Hackensack UMC, Hackensack, NJ, USAJesús F. San MiguelClínica Universidad de Navarra, CIMA, IDISNA, Pamplona, SpainShaji KumarDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USAPaul G. RichardsonJerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USAJoseph MıkhaelWinnMedFernando Leal da CostaMyeloma Clinic, Hematology Department, Instituto Português de Oncologia Francisco Gentil, Lisboa, PortugalMeletios Α. DimopoulosDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceChiara ZingarettiBiostatistics and Clinical trial Unit, IRST-IRCCS, Meldola, ItalyNiels AbildgaardDepartment of Hematology, Odense University Hospital, Odense, DenmarkHartmut GoldschmidtDepartment of Internal Medicine V, University Hospital Heidelberg, Heidelberg, GermanyRobert Z. OrlowskiThe University of Texas MD Anderson Cancer Center, Houston, TX, USAWee Joo ChngNational University Cancer Institute, National University Health System, SingaporeHermann EinseleDepartment of Internal Medicine II, University Hospital Würzburg, Würzburg, GermanySagar LonialDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USABart BarlogieTisch Cancer Institute/Multiple Myeloma Program, Mt. Sinai Cancer Institute, New York, NY, USAKenneth C. AndersonJerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USAS. Vincent RajkumarDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USABrian G.M. DurieCedars-Sinai Comprehensive Cancer Center, Los Angeles, CA, USAElena Zamagni
2017en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0